# Blood coagulation factors and risk of venous thromboembolism: a population-based study

**Authors:** Anna Erhard, Dennis Freuer, Annette Peters, Margit Heier, Christa Meisinger, Jakob Linseisen

PMC · DOI: 10.1186/s40001-025-03799-3 · European Journal of Medical Research · 2026-01-11

## TL;DR

This study explores how blood coagulation factors relate to the risk of venous thromboembolism in a general population.

## Contribution

The study identifies non-linear associations between specific coagulation factors and VTE in a population-based sample.

## Key findings

- The self-reported VTE prevalence was 3.2% in the study population.
- Protein C, protein S, and aPTT showed non-linear inverse associations with VTE.
- Most coagulation factors did not differ between individuals with and without VTE.

## Abstract

The prevalence of venous thromboembolism (VTE) and the impact of blood coagulation factors on the occurrence of VTE in the general population have been rarely studied.

In the KORA-Fit (S4) study with n = 805 participants (53% females) with a mean age of 62.4 (SD 5.7) years, the prevalence of physician-diagnosed VTE was assessed during a face-to-face interview. Plasma concentrations of antithrombin, fibrinogen, factor VIII, d-dimer, protein C, and protein S activity were analyzed; additionally, aPTT and prothrombin time were assessed as screening tests. The associations between coagulation factors and VTE were analyzed using multivariable logistic regression models. Non-linear associations were explored using restricted cubic splines.

The self-reported prevalence of VTE was 3.2%. The blood coagulation factors examined did not differ between individuals with and without VTE, except for factor VIII. In multivariable analyses, protein C (adjusted p = 0.008), protein S (adjusted p = 0.008), and aPTT (adjusted p = 0.016) were non-linearly inversely associated with VTE.

Our findings in a middle-aged and elderly population demonstrate significant associations between specific blood coagulation factors and the prevalence of VTE. However, these hypothesis-generating findings must be confirmed in prospective cohort studies. Also, research on the complex interactions between coagulation factors and patient-specific risk factors in the pathogenesis of VTE is warranted.

The online version contains supplementary material available at 10.1186/s40001-025-03799-3.

## Linked entities

- **Proteins:** antithrombin (antithrombin protein), FGB (fibrinogen beta chain)
- **Diseases:** venous thromboembolism (MONDO:0005399)

## Full-text entities

- **Genes:** F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, PROC (protein C, inactivator of coagulation factors Va and VIIIa) [NCBI Gene 5624] {aka APC, PC, PROC1, THPH3, THPH4}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}
- **Diseases:** VTE (MESH:D054556), Blood coagulation (MESH:D001778)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12882583/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12882583/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12882583/full.md

---
Source: https://tomesphere.com/paper/PMC12882583